Vectus Biosystems Ltd (vbs) Logo

Vectus Biosystems Ltd (VBS)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials
News
Announcements

VBS ASX Chart

Snapshot

Vectus Biosystems Limited (VBS) is developing treatments for fibrosis, including for three of the largest diseases in the fibrotic market, namely heart, kidney and liver diseases. Funds from the IPO and from two subsequent fundraisings were used predominantly to develop the Company's lead compound, VB0004, which aims to treat the hardening of functional tissue and high blood pressure.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2026 YTD
1 Year
vs Sector (1yr) +357.35%
vs ASX 200 (1yr) +318.53%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,949 of 2,337
Sector Rank 183 of 241

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies CMB / IXC / IVXDB
EPS -$0.026
DPS $0.00
Book Value Per Share -$0.013

Broker Consensus

VBS is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Rosebery NSW 2018
Website www.vectusbiosystems.com.au
Registry Computershare
Auditor UHY Haines Norton Chartered Accountants (UHY)
Date Listed 23 Feb 2016

Upcoming Calendar (Forecasted)

Date Event
28/08/2026 Report (Prelim)
28/09/2026 Report (Annual)
25/02/2027 Report (Interim)

Former Company Names

  • Vectus Biosystems Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

VBS directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
04/12/23 Karen Duggan Issued 19,842 $0.315 $6,250 As advised by the company
28/12/22 Maurie Stang Issued 12,500 $0.80 $10,000 Participation in share purchase plan
28/12/22 Susan Pond Issued 18,750 $0.80 $15,000 Participation in share purchase plan
28/12/22 Ronald Shnier Issued 37,500 $0.80 $30,000 Participation in share purchase plan
14/12/22 Maurie Stang Issued 316,000 $0.885 $279,660 Director remuneration
28/09/22 Maurie Stang Buy +285,952 $0.668 $191,015 As advised by the company
28/09/22 Maurie Stang Buy +2,000,000 $0.50 $1,000,000 Conversion of convertible notes
28/09/22 Maurie Stang Exercise 2,000,000 $0.50 $1,000,000 Conversion of convertible notes
09/11/21 Ronald Shnier Buy +208,291 $0.544 $113,265 Conversion of convertible notes
09/11/21 Ronald Shnier Exercise 208,291 $0.544 $113,265 Conversion of convertible notes
20/01/20 Karen Duggan Issued 75,000 $0.55 $41,250 Conversion of securities
20/01/20 Karen Duggan Issued 75,000 $0.55 $41,250 Conversion of securities
20/12/19 Ronald Shnier Issued 200,000 $0.50 $100,000 Purchase of convertibles
20/12/19 Maurie Stang Issued 2,000,000 $0.50 $1,000,000 Purchase of convertibles
03/10/19 Peter Bush Buy +100,000 $0.79 $79,000 Conversion of securities
03/10/19 Peter Bush Exercise 100,000 $0.79 $79,000 Conversion of securities
05/12/16 Maurie Stang Issued 100,000 $1.57 $157,000 Issue of securities
05/12/16 Karen Duggan Issued 2,000 $1.57 $3,140 Issue of securities
05/12/16 Karen Duggan Issued 175,000 $1.57 $274,750 Issue of securities
05/12/16 Peter Bush Issued 100,000 $1.57 $157,000 Issue of securities

Director Interests

The current holdings of VBS directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Linda Walters 30/06/2025 31,667 N/A N/A N/A
Ronald Shnier 30/06/2025 N/A 345,791 N/A N/A
Maurie Stang 30/06/2025 4,889,452 N/A 316,000 N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Sep 5, 2025.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Kefford Holdings Pty Ltd <The Kefford Family A/C> 5,187,623 9.73%
Ajjika Technology Pty Limited <The Ajjika A/C> 3,200,000 6.00%
Bernard Stang 2,764,500 5.18%
J P Morgan Nominees Australia Pty Limited 2,705,329 5.07%
Energy Trading Systems Pty Ltd <The MPF A/C> 2,562,500 4.80%
Maurie Stang 2,285,952 4.29%
Towns Corporation Pty Ltd <Pae Family A/C> 1,984,976 3.72%
Gleneagle Securities Nominees Pty Limited 1,611,596 3.02%
Bennelong Resources Pty Ltd <John Egan Super Fund A/C> 1,500,000 2.81%
Spinite Pty Ltd 1,435,773 2.69%
Citicorp Nominees Pty Limited 1,168,124 2.19%
Grizzly Holdings Pty Limited 999,680 1.87%
Gleneagle Securities (Aust) Pty Ltd 938,675 1.76%
Exit Out Pty Ltd <The Discretionary A/C> 900,000 1.69%
Buttonwood Nominees Pty Ltd 859,112 1.61%
Robert Richter + Anne Lyell Richter <Robert Richter S/F No2 A/C> 825,291 1.55%
Esklaw Pty Ltd <Tom Forrester Family A/C> 814,000 1.53%
T S Rai 2 Pty Ltd <Websta Super Fund A/C> 800,000 1.50%
Paul Alexander Ehrlich + Lauren Stacey Ehrlich <PAE & LSE Super Fund A/C> 730,000 1.37%
TDF Properties Pty Ltd <The TDF Property A/C> 599,339 1.13%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 72 161 57 183 69 542

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Karen Duggan 05/09/2025 3,278,500 6.15
Maurie Stang 05/09/2025 4,858,952 9.11
Kefford Holdings Pty Ltd 27/05/2026 7,122,623 11.58
Regal Funds Management Pty Ltd 27/05/2026 4,009,280 6.52

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
27-05-26 Kefford Holdings Pty Ltd 1,943,955 9.83 11.58

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
27-05-26 Regal Funds Management Pty Ltd 474,616 8.43 6.52

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2025 $0.04 30 June
2024 $0.077 28 June
2023 $0.44 30 June
2022 $0.985 30 June
2021 $1.35 30 June
2020 $0.72 30 June
2019 $0.34 28 June
2018 $0.85 29 June
2017 $1.40 30 June
2016 $1.36 30 June
VBS Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.